Society for Research on Nicotine and Tobacco

Member Login

Forgot Your Login?


Society for Research on Nicotine and Tobacco
2424 American Lane
Madison, WI 53704
Tel: 608.443.2462
Fax: 608.443.2474

2014 SRNT 20th Annual Meeting

February 5-8, 2014
Sheraton Seattle Hotel
Seattle, Washington, USA


2014 Final Program - PDF
2014 Abstract Book - PDF
2014 Rapid Response Abstract Book - PDF
Schedule-at-a-Glance - PDF
Program Addendum - PDF

Program Committee

2014 SRNT Annual Meeting Program Committee

Registration Form

Online Registration for SRNT Members is available in the Members Only section.
Non-Members wishing to attend the conference may register here.

Downloadable 2014 Registration Form - PDF


The abstract submission site is closed. Rapid response abstracts are being reviewed. Emails as to abstract status will be sent to corresponding authors within the next two weeks.

Airport Transportation Options

There are several ways to get from Sea-Tac Airport to the Sheraton Hotel.  Please visit the links below to learn more about the light rail, taxi, and shuttle options.

Continuing Education Credits

Please click here for information about obtaining credits.


Exhibit at the 2014 SRNT Annual Meeting!

Thank you to all of the companies exhibiting at the 2014 SRNT Annual Meeting

Borgwaldt KC Inc.
FDA Center for Tobacco Products
Hogrefe Publishing
Pfizer, Inc.
Vitalograph Inc.

Hotel Accommodations

The Sheraton Seattle, site of the SRNT Annual Meeting, is now sold out of sleeping rooms. Are you still looking for a hotel reservation? SRNT has reserved a small block of rooms at the Homewood Suites Hilton in downtown Seattle, just a short few blocks from the Sheraton Seattle. To secure your reservation, please call the hotel at 1-800-225-5466 and mention that you are with the SRNT meeting to secure the discounted rate of $169 per night. If you have any questions, please contact the SRNT office at

Sheraton Seattle --- Sold Out!

The negotiated room rate at the Sheraton Seattle is $207 single or double and does not include a 15.6% tax and $2.00 TIA that is applied at check-out per day. Reserve your room no later than January 8, 2014. Or call at +1-888-627-7056 and let them know you are attending the SRNT Annual Meeting.

The Sheraton Seattle is located in the heart of the downtown corridor, close to restaurants, shopping, and entertainment. Confirm your reservation soon!


Plan to attend your Network meeting in Seattle!

Wednesday, February 5, 2014
1:00 p.m. - 2:00 p.m.
Basic Science Network
Global Network
Treatment Network

Wednesday, February 5, 2014
2:30 p.m. - 3:30 p.m.
Genetics Network
Public Policy Network
Tobacco-Related Health Disparities Network

Find out more about your Network here.

Trainee Network Mixer

Have training opportunities or plan to hire postdocs/faculty? Attend a mixer event at the 2014 SRNT Annual Meeting!

Does your institution anticipate having training opportunities for students (e.g., internships) or hiring for post-doctoral fellowships or faculty positions in 2014 or 2015? Would you like an opportunity to network with potential candidates? The SRNT Trainee Network Advisory Board invites you to attend our 2nd annual mixer event during the 2014 SRNT Annual Meeting in Seattle, WA.

When: Thursday, February 6, 7:15 p.m.-8:15 p.m.
Where: Sheraton Seattle Hotel (exact location TBA)

Purposes of this event are to promote networking opportunities for trainees and potential future mentors/colleagues and to provide an informal setting in which trainees can build peer networks. Pre-doctoral and post-doctoral trainees and new/early-stage investigators will be invited to attend. Appetizers and drinks will be provided.

If you represent an institution that may have training or job opportunities available and are interested in attending this event, please email Amanda Mathew, Ph.D. at by January 15, 2014.

Thank you and we look forward to a great event!

Pre-Conference Workshops

Register for your choice of six Pre-Conference Workshops scheduled for Wednesday, February 5, 2014 from 8:00 a.m.-12:00 noon.
For more information please click here.

Speaker Information

Speaker Guidelines for Audio/Visual Presentations

Poster Presentation Guidelines

Transdisciplinary Discussions

Wednesday, February 5 from 4:00 p.m.-5:00 p.m.

These roundtable sessions have been selected to address a diverse array of pressing questions in our field. They will be moderated by world leading experts who will stimulate and encourage group discussion. These sessions are designed to be transdisciplinary – covering preclinical and clinical research and diverse methodologies. You do not need to be an expert in the subject area to attend a session – in fact we encourage that you cross boundaries and take the opportunity to participate in new topical discussions that will develop novel ideas and viewpoints.

Future Directions for Genomics Research
Moderators: Jennifer Ware and Jaakko Kaprio

This session will discuss the future of genetic and genomic research. The discussion will focus on three themes: 1) the role of phenotype refinement in gene discovery; 2) Mendelian randomization: using genetic discoveries to causality of smoking-related associations; and 3) the value of other "omic" methodologies, including metabolomics and proteomics in tobacco addiction genetic studies.

Behavioral Approaches to Cessation: What Works, What Doesn't and Why So Little Research? And Do Smokers Care?
Moderators: Saul Shiffman and Tom Brandon

Several commentators have noted the relatively slow progress over the last several decades in the development of behavioral approaches to treating tobacco dependence, and also noted the low rates of treatment utilization by smokers. Is this a fair assessment? Discussion will focus on the state-of-the-art behavioral interventions, how to reinvigorate this area of research, and potential directions for future treatment development.

Bridging the Gap Between Preclinical and Clinical Findings: Forward and Reverse Translation
Moderators: Eden Evins and Caryn Lerman

Preclinical models play a vital role in elucidating the neurobiological substrates of nicotine addiction and identifying potential therapeutic targets. To advance "forward translation" of findings to nicotine addiction treatment development, there is a critical need to establish the predictive validity of a wide range of existing animal behavior assays. In parallel, a "reverse translation" approach may focus on developing novel animal paradigms that tap understudied aspects of human nicotine addiction, such as motivation, expectations and trajectories of use. Opportunities and challenges in transdisciplinary and translational research on nicotine addiction treatment will be discussed during this roundtable session.

Nicotine and Cognitive Enhancement: Addressing Apparent Discrepancies Between Animal and Human Data
Moderators: Robert West and Marcus Munafo

There is a widespread belief that nicotine can enhance a range of important cognitive functions. However, while research with other species appears to support this idea, studies with humans have mostly been consistent with a withdrawal relief model rather than a positive enhancement model, although distinguishing between these is methodologically challenging. This discussion will provide an opportunity for sharing of information across the human and non-human domains to help gain a more accurate and complete understanding of the phenomena.

Regulatory Science of Tobacco Control: Opportunities and Implications for Animal and Human Laboratory Research
Moderators: Eric Donny and Dorothy Hatsukami

This discussion will describe a transdisciplinary approach to tobacco regulatory science. The following topics will be discussed: 1) what is tobacco regulatory science; 2) what are the critical components involved in the evaluation of tobacco products; 3) how do we integrate these components; and 4) how will these components be used to inform impact of a new or modified tobacco product on public health?

Dual Use of Electronic and Tobacco Cigarettes - Why Some E-cigarette Users Still Need to Smoke?
Moderators: Maciej Goniewicz and Neal Benowitz

Findings from population and clinical studies suggest that a significant proportion of e-cigarette users also continue to smoke cigarettes. Dual use represents a failure of quitting entirely since smokers might be using e-cigarettes where or when they can't smoke, and still smoking when they are able. It remains unclear why so many smokers replace only some of their cigarettes with an alternative product. During this transdisciplinary session we will discuss the reasons for dual use, how dual use might affect cigarette withdrawal symptoms, smoking reward, and cigarette dependence, and how dual use of the products is related to outcomes on public health, such as cessation attempts and success.

Welcome to Seattle!


Send an email to Jane Shepard at